Selinexor in relapsed/refractory multiple myeloma

by Joshua Richter, Deepu Madduri, Shambavi Richard, Ajai Chari
Published 2020-06-01

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

by Larysa Sanchez, Alexandra Dardac, Deepu Madduri, Shambavi Richard, Joshua Richter
Published 2021-01-01

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies

by Guido Lancman, Suzanne Arinsburg, Jeffrey Jhang, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Joshua Richter, Ajai Chari
Published 2018-11-01

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

by Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Lowena Tam, Daniel Verina, Ajai Chari
Published 2021-01-01

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

by Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sundar Jagannath, Samir Parekh, Deepu Madduri
Published 2020-07-01